|
US2020376087A1
|
|
Compositions, systems, and methods for treating or reducing hypoxia-ischemia induced brain damage and neurobehavioral dysfunction in neonates
|
|
US2020360527A1
|
|
Molecular-Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Intrarenal Deposition and Bioavailability
|
|
US2020317750A1
|
|
Molecular-Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Intrarenal Deposition and Bioavailability
|
|
US2020362016A1
|
|
Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta
|
|
US2019365922A1
|
|
Method for the production of precisely sized macro- and micro-elp containing particles for the delivery of therapeutic agents
|
|
US2018008721A1
|
|
Kidney-targeted drug delivery systems
|
|
EP3785725A1
|
|
Composition and method for therapeutic agent delivery during pregnancy
|
|
US2016110890A1
|
|
Medical image processing method
|
